INNATE PHARMA - 1H - Technical analysis published on 03/07/2023 (GMT)
- 224
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Analysis too old. There are no more charts available.
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
89%
0%
11%
My opinion
Bullish above 2.902 EUR
My targets
3.051 EUR (+0.96%)
3.147 EUR (+4.14%)
My analysis
The bullish trend is currently very strong on INNATE PHARMA. As long as the price remains above the support at 2.902 EUR, you could try to benefit from the boom. The first bullish objective is located at 3.051 EUR. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 3.147 EUR as an objective. Crossing it would then enable buyers to target 3.211 EUR. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
Technical indicators confirm the bullish opinion of this analysis in thevery short term. However, be careful of excessive bullish movements. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8.6
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Archi. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
INNATE PHARMA rating 3.022 EUR. The price registered an increase of +2.65% on the session with the lowest point at 2.898 EUR and the highest point at 3.022 EUR. The deviation from the price is +4.28% for the low point and 0% for the high point.2.898
3.022
3.022
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new LOW record (1st january)
Type : Bearish
Timeframe : Weekly
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of INNATE PHARMA in 1H shows a strongly overall bullish trend. The signals given by the moving averages are 89.29% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, 16 technical indicators on 18 studied are currently bullish. The Central Indicators scanner found this result concerning these indicators:
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 2.589 | 2.804 | 2.902 | 3.022 | 3.051 | 3.147 | 3.211 |
| Change (%) | -14.33% | -7.21% | -3.97% | - | +0.96% | +4.14% | +6.25% |
| Change | -0.433 | -0.218 | -0.120 | - | +0.029 | +0.125 | +0.189 |
| Level | Major | Intermediate | Minor | - | Major | Major | Minor |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 2.603 | 2.713 | 2.829 | 2.939 | 3.055 | 3.165 | 3.281 |
| Camarilla | 2.882 | 2.903 | 2.923 | 2.944 | 2.965 | 2.985 | 3.006 |
| Woodie | 2.605 | 2.715 | 2.831 | 2.941 | 3.057 | 3.167 | 3.283 |
| Fibonacci | 2.713 | 2.800 | 2.853 | 2.939 | 3.026 | 3.079 | 3.165 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 2.316 | 2.548 | 2.686 | 2.918 | 3.056 | 3.288 | 3.426 |
| Camarilla | 2.722 | 2.756 | 2.790 | 2.824 | 2.858 | 2.892 | 2.926 |
| Woodie | 2.269 | 2.525 | 2.639 | 2.895 | 3.009 | 3.265 | 3.379 |
| Fibonacci | 2.548 | 2.689 | 2.777 | 2.918 | 3.059 | 3.147 | 3.288 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.995 | 2.375 | 2.589 | 2.969 | 3.183 | 3.563 | 3.777 |
| Camarilla | 2.639 | 2.693 | 2.748 | 2.802 | 2.857 | 2.911 | 2.965 |
| Woodie | 1.911 | 2.334 | 2.505 | 2.928 | 3.099 | 3.522 | 3.693 |
| Fibonacci | 2.375 | 2.602 | 2.742 | 2.969 | 3.196 | 3.336 | 3.563 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 63.43 | |
| MACD (12,26,9): | 0.0350 | |
| Directional Movement: | 27.838 | |
| AROON (14): | 35.714 | |
| DEMA (21): | 2.960 | |
| Parabolic SAR (0,02-0,02-0,2): | 2.843 | |
| Elder Ray (13): | 0.072 | |
| Super Trend (3,10): | 2.875 | |
| Zig ZAG (10): | 3.000 | |
| VORTEX (21): | 1.1010 | |
| Stochastique (14,3,5): | 70.05 | |
| TEMA (21): | 2.976 | |
| Williams %R (14): | -28.57 | |
| Chande Momentum Oscillator (20): | 0.132 | |
| Repulse (5,40,3): | 0.0260 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.1180 | |
| Courbe Coppock: | 8.62 |
| MA7: | 2.896 | |
| MA20: | 2.980 | |
| MA50: | 3.168 | |
| MA100: | 2.670 | |
| MAexp7: | 2.965 | |
| MAexp20: | 2.919 | |
| MAexp50: | 2.885 | |
| MAexp100: | 2.902 | |
| Price / MA7: | +4.35% | |
| Price / MA20: | +1.41% | |
| Price / MA50: | -4.61% | |
| Price / MA100: | +13.18% | |
| Price / MAexp7: | +1.92% | |
| Price / MAexp20: | +3.53% | |
| Price / MAexp50: | +4.75% | |
| Price / MAexp100: | +4.14% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
The latest news and videos published on INNATE PHARMA at the time of the analysis were as follows:
- Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
- Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
- Innate Pharma to Participate in Upcoming Investor Conferences
- Innate Pharma to Participate in Upcoming Investor Conferences
- Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis INNATE PHARMA - 1H